Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Aerovate Therapeutics, Inc. (AVTE)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 27,670,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Aerovate Therapeutics is a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Co.'s initial focus is on improving AV-101, its dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. AV-101, delivered using a dry powder inhaler, is designed to provide lung concentrations at or above those observed with the oral dose while limiting systemic levels of the drug.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 189,787 270,084 359,535 1,070,338
Total Sell Value $5,007,126 $6,360,074 $7,987,248 $16,365,965
Total People Sold 7 7 7 8
Total Sell Transactions 24 36 53 109
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 225
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gillies Hunter CHIEF MEDICAL OFFICER   •       –      –    2024-04-17 4 AS $22.30 $89,522 D/D (4,000) 3,251     -
   Gillies Hunter CHIEF MEDICAL OFFICER   •       –      –    2024-04-17 4 OE $1.74 $6,960 D/D 4,000 7,251     -
   Dake Benjamin T SEE REMARKS   •       –      –    2024-04-17 4 AS $22.32 $153,327 D/D (6,853) 1,291     -
   Dake Benjamin T SEE REMARKS   •       –      –    2024-04-17 4 OE $2.14 $14,665 D/D 6,853 8,144     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2024-04-16 4 AS $24.40 $246,971 D/D (10,000) 0     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2024-04-16 4 OE $2.14 $21,400 D/D 10,000 10,000     -
   Eldridge George A SEE REMARKS   •       –      –    2024-04-10 4 AS $26.77 $201,392 D/D (7,500) 1,960     -
   Eldridge George A SEE REMARKS   •       –      –    2024-04-10 4 OE $2.14 $16,050 D/D 7,500 9,460     -
   Grayzel David S.   –       •      –    2024-04-09 4 S $28.15 $334,478 I/I (11,882) 14,502     -
   Eldridge George A SEE REMARKS   •       –      –    2024-04-01 4 AS $31.23 $390,208 D/D (12,495) 1,960     -
   Eldridge George A SEE REMARKS   •       –      –    2024-04-01 4 OE $2.14 $26,739 D/D 12,495 14,455     -
   Dake Benjamin T SEE REMARKS   •       –      –    2024-04-01 4 AS $31.97 $106,317 D/D (3,325) 1,291     -
   Dake Benjamin T SEE REMARKS   •       –      –    2024-04-01 4 OE $10.61 $35,278 D/D 3,325 4,616     -
   Verwijs Marinus CHIEF TECHNICAL OFFICER   •       –      –    2024-04-01 4 AS $28.87 $154,697 D/D (5,300) 0     -
   Verwijs Marinus CHIEF TECHNICAL OFFICER   •       –      –    2024-04-01 4 OE $14.59 $77,327 D/D 5,300 5,300     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2024-04-01 4 AS $28.96 $300,033 D/D (10,000) 0     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2024-04-01 4 OE $2.14 $21,400 D/D 10,000 10,000     -
   Gillies Hunter CHIEF MEDICAL OFFICER   •       –      –    2024-03-28 4 AS $29.50 $265,500 D/D (9,000) 3,251     -
   Gillies Hunter CHIEF MEDICAL OFFICER   •       –      –    2024-03-28 4 OE $2.14 $19,260 D/D 9,000 12,251     -
   Dake Benjamin T SEE REMARKS   •       –      –    2024-03-27 4 AS $27.97 $309,519 D/D (11,068) 1,291     -
   Dake Benjamin T SEE REMARKS   •       –      –    2024-03-27 4 OE $10.61 $117,431 D/D 11,068 12,359     -
   Dake Benjamin T SEE REMARKS   •       –      –    2024-03-25 4 AS $28.01 $96,119 D/D (3,432) 1,291     -
   Dake Benjamin T SEE REMARKS   •       –      –    2024-03-25 4 OE $10.61 $36,414 D/D 3,432 4,723     -
   Verwijs Marinus CHIEF TECHNICAL OFFICER   •       –      –    2024-03-19 4 AS $25.68 $138,243 D/D (5,300) 0     -
   Verwijs Marinus CHIEF TECHNICAL OFFICER   •       –      –    2024-03-19 4 OE $14.59 $77,327 D/D 5,300 5,300     -
  225 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us